36 filings
Page 2 of 2
8-K
e2yb3
14 Mar 22
Biodesix Announces Fourth Quarter and Year End 2021 Results and Highlights
6:12am
8-K
nzt0 q3pa5vebz6
7 Mar 22
Biodesix Announces Common Stock Purchase Agreement for up to $50 Million with Lincoln Park Capital
4:14pm
8-K
t9yb1
14 Feb 22
Core lung diagnostic testing revenues grow 49% for full-year 2021
9:55am
8-K
q242r19a9wjwpxtlb0hy
14 Feb 22
Core lung diagnostic testing revenues grow 49% for full-year 2021
8:01am
8-K
o7p 33br67
4 Jan 22
Biodesix Strengthens Financial Position with Equity Issuance and Amendment to Term Loan
4:06pm
8-K
gkq e9kenr53
8 Dec 21
Biodesix Announces Appointment of Successful Innovator and Scientific Professional Jon Faiz Kayyem, PhD to Board of Directors
8:34am
8-K
v1g3r8u
15 Nov 21
Biodesix Announces Third Quarter 2021 Results and Highlights
7:45am
8-K
tv98oa uxkf2
9 Sep 21
Regulation FD Disclosure
9:16am
8-K
gooq55a745
10 Aug 21
Biodesix Announces Second Quarter 2021 Results and Highlights
4:01pm
8-K
u6fcd3b b6b9
27 May 21
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
5302vyxoi2g3j
11 May 21
Biodesix Announces First Quarter 2021 Results
4:10pm
8-K
gn1nwgm8m5qhze
23 Mar 21
Biodesix Announces Closing of New $30 Million Term Loan
4:38pm
8-K
mv5aieb4zwkj0
16 Mar 21
Biodesix Announces Fourth Quarter and Full Year 2020 Results
2:53pm
8-K
8zfq92h37slc4ftbcqxv
8 Jan 21
Record quarterly revenue driven by strength in COVID-19 testing and growth in lung diagnostic testing
12:00am
8-K
4ojdo5 ekp
5 Jan 21
Biodesix Announces Hiring of Ryan Siurek as Chief Accounting Officer
12:00am
8-K
tflsjl54af0jh j77
10 Dec 20
Biodesix Announces Third Quarter 2020 Results and Provides Corporate Update
4:23pm